A New Drug Compound Shows Promise for Schizophrenia
Briefly

In a study published Dec. 14 in the Lancet, researchers report on a promising new treatment for the psychiatric disorder that could give patients better options.
This represents a new option, and a new approach in an area where there is still substantial need for advances in treatments, says Andrew Miller, chief operating officer of Karuna.
Read at time.com
[
add
]
[
|
|
]